baber/WOPTO huggingface dataset:
Patent DK-2757976-T3 (DK)
Inventor: BAKE NINA
IPC: A61F2/30
Filed: 2012-08-31
Granted: 2018-01-15
Abstract: The present invention provides a design method designing an implant specific drill bit comprising steps; e. determining or selecting a size and shape of an orthopedic implant comprising a circular shaped implant body and a centrally placed circular shaped extending post protruding from the bone contacting surface in a longitudinal y-axis direction of the implant; and f. selecting design parameters for the implant specific drill bit by; - selecting the width of the broadest part of the bone remover in a side view to correspond to, or to be slightly smaller than, the diameter of the implant body of the specific implant that is to be implanted; - selecting the rotational volume and the length of the central drill part to correspond to, or to be slightly smaller than, the diameter of the extending post of the specific implant that is to be implanted; -selecting the curvature of the cutting edge that is placed anywhere peripherally around or surrounding the central drill part of the implant specific drill bit to correspond to the curvature of the bone contacting surface of the implant.
Patent DK-2959070-T3 (DK)
Inventor: PARTRIDGE MARK
IPC: E04H1/12
Filed: 2013-11-29
Granted: 2018-01-02
Abstract: There is provided a ceiling panel for a pod room. The ceiling panel comprises one or more cover components movable between an open configuration and a closed configuration; and an actuation mechanism configured to move the one or more cover components from the closed configuration to the open configuration in response to a trigger. The ceiling panel may provide a specified percentage open area in the open configuration. The ceiling panel may be adapted to acoustically insulate the pod room in the closed configuration.
Patent DK-0447585-T3 (DK)
Inventor: PIECHACZEK DETLEF DR DIPL-CHEM
IPC: A61K39/00
Filed: 1990-03-22
Granted: 1995-05-29
Abstract: The immunoglobulin G preparation is free of aggregates, vasoactive substances and proteolytic enzymes and is thus suitable for all groups of patients, especially immunosuppressed patients, and is manufactured from a starting material which has been freed of coagulation factors and contains immunoglobulin G by treatment with 0.4 to 1.5% by volume octanoic acid and/or subsequent chromatography, in particular on an anion or cation exchanger or a hydrophobic chromatography matrix.
Patent DK-0420332-T3 (DK)
Inventor: HEMKER HENDRIK COENRAAD
IPC: C12Q1/56
Filed: 1990-09-21
Granted: 1995-07-03
Abstract: A method for determining the endogenous thrombin potential (ETP). which shows how much and for what length of time thrombin has been active in a sample of clotting blood or plasma. The ETP can be used for determining the effectiveness of treatment with antithrombotics of any type. Said ETP determination comprises adding to said sample a thrombin substrate, an activator of thrombin formation, a preparation of proteaseinhibitor and if desired a pharmaceutical for analysis . The thrombin substrate is preferably selected to not completely consume the amount of thrombin generated in the sample, to have a rate of conversion of the substrate which is proportional to the amount of thrombin present and to have a measurable conversion product resulting from the conversion by thrombin. Determination of the amount of conversion product leads to determination of the ETP. The choice of activator determines whether the effect is measured on the intrinsic or extrinsic clotting system, making it possible to determine the effect of the pharmaceutical, which is being analysed, on various parts of the clotting mechanism.
Patent DK-0463679-T3 (DK)
Inventor: MAXWELL IAN ERNEST
IPC: C07C9/16
Filed: 1991-06-17
Granted: 1994-06-20
Abstract: Process for producing gasoline components from a hydrocarbonaceous feed containing hydrocarbons comprising at least 4 carbon atoms, and hydrocarbons obtained thereby. The process comprises the following steps:   a) separating feed into a heavy fraction containing hydrocarbons comprising at least 7 carbon atoms, an intermediate fraction containing mainly hydrocarbons comprising 6 or 7 carbon atoms, and a light fraction containing hydrocarbons comprising at most 6 carbon atoms,   b) isomerizing at least part of the light fraction, c) combining effluent of step b) with intermediate fraction, and separating off a stream containing normal hydrocarbons and a stream containing branched hydrocarbons, and d) passing at least part of the stream containing normal hydrocarbons to isomerization step b). s
Patent DK-0502998-T3 (DK)
Inventor: CORRIGAN COLIN D SUITE
IPC: G01N/
Filed: 1990-12-10
Granted: 2000-01-31
Abstract: A portable detection and screening system for the detection of target vapors and/or target particulates associated with a defined class of target materials that includes explosives, chemical agents, drugs or narcotics, said system is disclosed comprising: sampling means (20; 100, 300, 200) for gathering a sample volume of air from a specific area on an individual or object that may contain vapor or particulate emissions of said target materials, said sampling means performing said gathering in a first sampling period, means (30; 400, 410; SCAV, PCAD) for concentrating said target vapors or vapors emanating from said target particulates contained in said sample volume of air, said means including means for collecting said target vapors or particulate emissions at a first location; means for transporting said collected target vapors or particulate emissions to a second location distinct from said first location; means (SCAP, 510) for desorbing said target vapors or particulate emissions at said second location in a second sampling period; and, detection means (80, 460; 90, 560) responsive to said target vapors or particulate emissions desorbed at said second location to generate a signal in response to the presence of said target materials in said sample volume, wherein said sampling means (20; 100, 200, 300) is adapted for collecting a new sample volume of air containing target vapors or particulate emissions at said first location during said second sampling period.
Patent DK-0521088-T3 (DK)
Inventor: MOURET PHILIPPE
IPC: A61B17/02
Filed: 1991-03-20
Granted: 1994-08-15
Abstract: An instrument for assisting surgical laparascopic or coelioscopic operations where the patient's anterior abdominal wall is formed with an aperture and is raised away from the patient's visceral organs comprises a wirelike body having a first part extending substantially in a plane and adapted to lie against the posterior face of the anterior abdominal wall, a second part extending transversely from the plane of the first part, having an outer end, and adapted to traverse the aperture in the abdominal wall, and a hook at the outer end of the second part adapted to be secured to a stationary support. After inflation of the patient's peritoneum to raise the anterior abdominal wall, the second part of the device is hooked under this wall and the outer end is hooked over a bracket to maintain the abdominal wall raised.
Patent DK-0527303-T3 (DK)
Inventor: HELLWIG VOLKER DR
IPC: C08L101/00
Filed: 1992-06-05
Granted: 1995-09-18
Abstract: The invention relates to an insulation layer-forming (intumescent) material for fire protection (flame retardant) based on specific quantities of substances forming a foam layer in a fire, such as ammonium salts of phosphoric acid or polyphosphoric acid, carbon-forming substances, melamine or melamine ester or melamine- formaldehyde resin and organochemical binders, the ratio of melamine or melamine ester or melamine-formaldehyde resin to the ammonium salt of phosphoric acid or polyphosphoric acid being 1:2 to 1:2.8 or 1:2.81 to 1:6.0.
Patent DK-0649464-T3 (DK)
Inventor: SELDEN RICHARD F
IPC: A61K35/36
Filed: 1992-11-05
Granted: 1998-03-02
Abstract: The present invention relates to transfected primary and secondary somatic cells of vertebrate origin, particularly mammalian origin transfected with exogenous genetic material (DNA) which encodes a desired (e.g. a therapeutic) product or is itself a desired (e.g. therapeutic) product, methods by which primary and secondary cells are transfected to include exogenous genetic material, including DNA targeting by homologous recombination, methods of producing clonal cell strains or heterogenous cell strains, methods of gene therapy in which the transfected primary or secondary cells are used, and methods of producing antibodies using the transfected primary or secondary cells. The present invention includes primary and secondary somatic cells, such as fibroblasts, keratinocytes, epithelial cells, endothelial cells, glial cells, neural cells, formed elements of the blood, muscle cells, other somatic cells which can be cultured and somatic cell precursors, which have been transfected with exogenous DNA which is stably integrated into their genomes or is expressed in the cells episomally. The exogenous DNA either encodes a product, such as a translational product (e.g. a protein) or a transcriptional product (e.g. a ribozyme or an anti-sense nucleic acid sequence) which is a therapeutic product or is itself a therapeutic product (e.g. DNA which binds to a cellular regulatory protein or alters gene expression). <IMAGE>
Patent DK-0606550-T3 (DK)
Inventor: HAENSCH EGON
IPC: B65H29/06
Filed: 1993-11-03
Granted: 1997-10-06
Abstract: Flat products (10) are fed to the reception region (18) by means of the conveying device (16). Arranged under the conveying device (16) is a transfer conveyor (22) which has individually controllable clamps (20) articulated on a wheel-like supporting member (30). The clamps (20) are controlled in such a way that, in the reception region (18), the clamp jaw (26) is directed forwards, as seen in the direction of rotation (U). In the reception region (18), the clamp (20) drops level with the product (10) and grasps the latter at the trailing edge (10'). During rotation about the axis of rotation (24) in relation to the transfer region (28), the clamp (20) is pivoted in the direction (S) opposite to the direction of rotation (U). In the transfer region (28), the products (10) are transferred to the processing device (12). <IMAGE>
Patent DK-0616650-T3 (DK)
Inventor: BAHIA HARDEV SINGH
IPC: A61F13/49
Filed: 1992-12-09
Granted: 1999-06-23
Abstract: Carboxymethyl cellulose fiber having a degree of substitution of at least 0.1, preferably 0.2-0.5, carboxymethyl groups per glucose unit is derived from solvent-spun cellulose fiber, for example by reaction with a strong alkali and a monochloroacetate reagent. The fiber has an absorbency of at least 8 grams, usually at least 15 grams, 0.9% saline solution per gram of fibre and a tenacity of at least 10, usually at least 15, cN/tex. It can be used for absorbent personal products.
Patent DK-0579797-T3 (DK)
Inventor: FORICHER JOSEPH
IPC: C07C49/04
Filed: 1993-02-01
Granted: 1999-10-25
Abstract: PCT No. PCT/CH93/00026 Sec. 371 Date Sep. 27, 1993 Sec. 102(e) Date Sep. 27, 1993 PCT Filed Feb. 1, 1993 PCT Pub. No. WO93/15091 PCT Pub. Date Aug. 5, 1993.Novel, racemic and optically active phosphorus compounds of the formula    <IMAGE>  I  wherein R signifies lower alkyl or lower alkoxy and R1 represents lower alkyl, cycloalkyl or substituted phenyl, are described. The compounds of formula I are useful in the form of complexes with a metal of Group VIII as catalysts for asymmetric hydrogenations and for enantioselective hydrogen displacements in prochiral allylic systems.
Patent DK-0630409-T3 (DK)
Inventor: LEVER ANDREW MICHAEL LINDSAY
IPC: A61K35/76
Filed: 1993-03-01
Granted: 2003-03-24
Abstract: The present invention relates to vectors and their use in gene transfer, In particular the invention provides a vector comprising nucleotides corresponding to the packaging nucleotides of a lentivirus, a heterologous gene, and, flanking the packaging nucleotide and the heterologous gene, sequences corresponding to those within and near the sufficient lentivirus LTR, for packaging, reverse transcription and integration of the vector into target cells and expression of the heterologous gene wherein said nucleotides comprise those corresponding at least substantially to the lentivirus 5' leader sequence and REV-responsive region.
Patent DK-0636119-T3 (DK)
Inventor: STEVENS RODNEY W
IPC: A61P9/00
Filed: 1993-02-18
Granted: 1997-12-22
Abstract: Certain novel phenylsubstituted cycloalkylurea compounds having the ability to inhibit the enzyme 5-lipoxygenase and having formula (I); wherein A is C1-C4 alkylene or C2-C6 alkenylene; each B is independently halogen, C1-C4 alkyl, C2-C8 alkoxyalkyl or halosubstituted C1-C4 alkyl; X is methylene or ethylene; M is hydrogen or a pharmaceutically acceptable cation; A r is phenyl or mono-, di- or tri-substituted phenyl wherein the substituents are each independently selected from halogen, C1-C4 alkyl, C1-C4 alkoxy, halosubstituted C1-C4 alkyl, (C1-C4 alkyl)phenoxy, (C1-C4 alkoxy)phenoxy, halosubstituted phenoxy, halosubstituted (C1-C4 alkyl)phenoxy, phenylthio, (C1-C4 alkyl)phenylthio, (C1-C4 alkoxy)phenylthio, halosubstituted phenylthio and halosubstituted (C1-C4 alkyl)phenylthio; A, B and Ar may be attached at any available position on the ring; m is 0 or 1; and n is 0, 1 or 2. These compounds are useful in the treatment or alleviation of inflammatory diseases, allergic conditions and cardiovascular diseases in mammals and as the active ingredient in pharmaceutical compositions for treating such conditions.
Patent DK-0652291-T3 (DK)
Inventor: OHNO TSUNEYA
IPC: C12N15/11
Filed: 1993-07-07
Granted: 2003-06-23
Abstract: A probe for diagnosing infectious diseases in which the probe comprises the base sequence set out in SEQ. ID. No. 7 and specifically reacts with DNA of Staphylococcus epidermidis.
Patent DK-0625571-T3 (DK)
Inventor: WAGNER FRITZ PROF DR
IPC: C12N9/80
Filed: 1994-05-11
Granted: 2000-12-18
Abstract: N-5-Monosubstituted hydantoins can be converted by fermentation or enzymatically into the enantiomerically pure L- alpha -amino acid. The object comprises microorganisms which are simple to cultivate and make high L- alpha -amino acid yields possible from various substrates. The microorganisms DSM 7329 and 7330 are suitable for the production of L- alpha -amino acids from corresponding hydantoins or carbamoyl- alpha -amino acids. The reaction is preferably carried out with dormant microorganisms. Production of various L- alpha -amino acids.
Patent DK-0618209-T3 (DK)
Inventor: RENARD PIERRE
IPC: A61P25/28
Filed: 1994-03-24
Granted: 1999-08-23
Abstract: The invention relates to the compounds of formula (I): <IMAGE>  in which A, R1, R2 and R4 are as defined in the description. Medicaments.
Patent DK-0707457-T3 (DK)
Inventor: HAHN SOONKAP
IPC: A61B17/42
Filed: 1994-06-28
Granted: 2000-11-13
Abstract: The childbirth-assisting device uses an automatically synchronized expandable pneumatic girdle-to externally augment the secondary force of labor. The pneumatic girdle is fitted around the abdomen of the woman and the girdle is inflated to create a downward pressure on the abdomen when a contraction occurs. The synchronization of the girdle's inflation and the contractions is provided by an electronic controller which receives a signal from an intra-uterine monitor indicating a contraction and causes the girdle to inflate at a certain rate until a preset intra-uterine pressure is attained. Once the intra-uterine pressure reaches the pre-set pressure, the girdle pressure is maintained until the offset of the contraction is detected, at which time the girdle is deflated.
Patent DK-0667747-T3 (DK)
Inventor: BAUER WERNER
IPC: A23L27/60
Filed: 1994-09-06
Granted: 2000-04-25
Abstract: The present invention relates to a food product which comes in the form of a dehydrated oil-in-water emulsion which can be reconstituted by adding water so as once again to form a stable emulsion of the mayonnaise or salad dressing type, and to a process for preparing the said dehydrated emulsion.
Patent DK-0725644-T3 (DK)
Inventor: ECKER KARL-WILHELM
IPC: A61K31/56
Filed: 1994-09-22
Granted: 1999-02-08
Abstract: The invention relates to the use of budesonide to treat conditions arising from reduced enteral fluid resorption, especially post-operative conditions. These conditions are, for example, diarrhoeas following every kind of intestinal resection, in atrophy of the intestinal mucous membrane, in amyloiditis and Whipple's disease, in adrenal insufficiency, in indigenous and tropical sprue, in HIV infection or following exsudative enteropathy.
Patent DK-0745124-T3 (DK)
Inventor: WEINSTEIN JASMINDER
IPC: C12P21/02
Filed: 1995-02-13
Granted: 1999-02-01
Abstract: A novel mammalian cell cycle protein, p55CDC, DNA sequences encoding p55CDC, and a method for producing the protein are described. Also described are methods for detecting p55CDC and methods for modulating cell division by compounds which control the level or activity of p55CDC or p55CDC-associated protein complexes.
Patent DK-0797609-T3 (DK)
Inventor: KISSEL THOMAS
IPC: A61K9/16
Filed: 1995-02-23
Granted: 2000-08-07
Abstract: PCT No. PCT/EP95/00655 Sec. 371 Date Apr. 24, 1997 Sec. 102(e) Date Apr. 24, 1997 PCT Filed Feb. 23, 1995 PCT Pub. No. WO95/23175 PCT Pub. Date Aug. 31, 1995The invention relates to new polyesters of a polyol containing substituents with electrolyte properties with polymeric hydroxycarboxylic esters, their method of preparation and their use. The polyesters are particularly suitable for use in the preparation of sustained-release drugs.
Patent DK-0754059-T3 (DK)
Inventor: BROOKS PETER
IPC: A61P35/00
Filed: 1995-03-09
Granted: 2004-04-13
Abstract: Angiogenesis is inhibited in a tissue by admin. of a compsn. comprising an alpha vbeta 3 antagonist.
Patent DK-0765829-T3 (DK)
Inventor: WILHELM KLAUS
IPC: B65G65/36
Filed: 1996-08-05
Granted: 1999-03-22
Abstract: The device has a suction head (10) connected to a suction pipe (15) with a suction opening (31). This head has a float (11) which floats on or in the material and holds the head above it. A vibration generator (35) can cause the head or float to vibrate. The float preferably contains at least one air chamber (33) and has an opening (27) on its underside. Inside, preferably at the float's centre, is an open bottomed suction chamber (13) with a suction opening (29) containing the pipe's opening.
Patent DK-0777010-T3 (DK)
Inventor: HEILEN WERNFRIED
IPC: D06P1/16
Filed: 1996-11-15
Granted: 2003-04-14
Abstract: A polysiloxane-polyoxyethylene-polyoxypropylene tri-block copolymer of formula (I) where the ratio of x/y is 0.12-0.20 is claimed. R1 = 1-8 C alkyl; R2 = -(CH2)pO-; p = 2, 3 or 4; R3 = H or 1-4 C alkyl; n = 40-80; m = 3-10; x = 3-6; y = 20-30.
Patent DK-0817742-T3 (DK)
Inventor: HOBERG ELMAR
IPC: B62H3/08
Filed: 1996-01-25
Granted: 1999-06-28
Abstract: The invention concerns a device for parking two-wheeled vehicles, in particular bicycles (8). The device comprises a wheel holder (2) into which a vehicle wheel (7) is inserted. In its lower region, the vehicle wheel (7) is supported in the wheel holder (2) only in the vicinity of the tyres on two profiled support points (10). Means formed by a spring-loaded lever arm (4) which can pivot in the plane of the wheel (7) and has a profiled pressure roller (5) disposed at its wheel end are further provided for introducing force into the upper wheel region.
Patent DK-0815075-T3 (DK)
Inventor: BURNS MICHAEL EUGENE
IPC: C07C309/42
Filed: 1996-03-04
Granted: 2001-01-29
Abstract: The synthesis of phenol sulfonate esters of alkanoyl amino acids is conducted in the presence of aqueous base to provide bleach activator compounds. Thus, the acid chloride of N-nonanoyl-6-aminocaproic acid is reacted with the sodium salt of p-phenol sulfonate in the presence of water at a pH in the range of about 9 to about 12 to yield the corresponding phenol sulfonate ester. The synthesis of the phenol sulfonate ester of the monononyl amide of adipic acid is also illustrated.
Patent DK-0827505-T3 (DK)
Inventor: JOHN P MALLAMO
IPC: A61K31/55
Filed: 1996-04-03
Granted: 2003-02-17
Abstract: Esters of hydroxyl-containing indolocarbazoles and acids containing selected solubilizing groups are provided. Compositions including the indolocarbazole esters and methods for the use of the indolocarbazole esters are also provided.
Patent DK-0843557-T3 (DK)
Inventor: ROMAGNANI SERGIO
IPC: A01N63/00
Filed: 1996-07-19
Granted: 2003-03-10
Abstract: The lymphocyte ativation gene (LAG-3) is a member of the immunoglobulin superfamily that is selectively transcribed in human activated T and NK cells. Surface LAG-3 expression correlated with IFN-gamma but not IL-4, production in antigen-stimulated T-cells and it was up-regulated by IL-12 and is preferentially associated with CD4+ T-cells producing Th1-type cytokines. The presence of LAG-3 on the surface of Th1 lymphocytes is used as a marker to detect and identify Th1 lymphocytes and differentiate them from Th2 lymphocytes. Monoclonal antibodies to LAG-3 are used in methods of detecting and isolating Th1 cells as well as methods of diagnosing Th1-mediated disease. The present invention also relates to methods of treating infectious diseases, cancer, and disorders assocated with Th1/Th2 imbalance.
Patent DK-0846717-T3 (DK)
Inventor: STANDKE BURKHARD DR
IPC: C08G77/24
Filed: 1997-10-11
Granted: 2001-04-17
Abstract: Water-based, organopolysiloxane-containing compositions, which are largely free from organic solvent, show a flash point of above 70 degrees C and do not release alcohol when diluted with water. These compositions contain polysiloxanes of formula HOÄSi(A)(CH3)z(OH)1-zOÜaÄSi(B)(R<2>)y(OH)1-yOÜbÄSi(C)(CH3< /SB>)OÜcÄSi(D)(OH)OÜdH . (HX)e (I), where A = amino-alkyl group derived from formula H2N(CH2)f(NH)g(CH2)hSi(OR)3-z(CH3)z (II); R = linear, branched or cyclic 1-8C alkyl, or aryl; f = 0-6; g = 0 if f = 0, or g = 1 if f = more than 0; h = 0-6; z = 0-1; B = fluoroalkyl group derived from formula R<1>-Y-(CH2)2Si(R<2>)y(OR)3-y (III); R<1> = mono-, oligo- or per- fluorinated 1-9C alkyl or aryl; Y = CH2, O or S; R<2> = as for R; y = 0-1; C = alkyl group derived from formula R<3>-Si(CH3)(OR)2 (IV); D = alkyl group derived from R<3>-Si(OR)3 (V); R<3> = linear, branched or cyclic 1-8C alkyl; X = residue of (in)organic acid; a, b = more than 0; c, d, e = 0 or more; and a+b+c+d = at least 2. Also claimed is a process for the production of these compositions.
Patent DK-0860571-T3 (DK)
Inventor: SINSTEDEN CLAUDIA
IPC: E05D7/00
Filed: 1997-11-21
Granted: 2004-03-22
Abstract: The first half (30) of the hinge (100) is secured to the front surface (2) of the fixed door- or window-frame, and the second half (40) to that of the leaf (20). The first half extends above the second one to accommodate a pin (6) passing through both, and which forms the hinge axis (A). The pin is movable in a straight guide in the transverse direction, so as to adjust the leaf position inside the frame. The external screw (50) adjusting the pin is actuated from the top of the hinge, and its axis can be parallel to the hinge axis. The pin can be accommodated in a bush (8) which is guided in a recess allowing no free movement in the hinge half (42).